FDA Calendar

Nov. 4-9, Anaheim, Calif.

AMERICAN COLLEGE OF ALLERGY, ASTHMA & IMMUNOLOGY ANNUAL MEETING 2005

Includes presentations on allergists and cost-effective asthma treatment and immunology programs

Nov. 8-13, Philadelphia

RENAL WEEK 2005 - AMERICAN SOCIETY OF NEPHROLOGY

Research on why kidneys fail and translating basic mechanisms of disease progression into renal therapies

Nov. 9, New York

CIBC WORLD MARKETS 16th ANNUAL HEALTHCARE CONFERENCE

Health care industry representatives discuss Medicare/Medicaid reform, generic drug regulation, product safety, patent issues and managed care

Nov. 10, Rockville, Md.

ANESTHETIC AND LIFE SUPPORT DRUGS ADVISORY COMMITTEE (FDA)

Meeting opens to public at the start then becomes closed session to permit discussion and review of trade secret and/or confidential information

Nov. 10-13, San Francisco

19th ANNUAL CONGRESS OF THE AMERICAN COLLEGE OF PHLEBOTOMY

Includes launch of AngioDynamics Inc.'s Sotradecol varicose vein treatment

Nov. 11-15, San Francisco

56th ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES

Hepatologists and hepatology health professions exchange latest liver disease research and discuss treatment outcomes; includes presentation from Schering-Plough on oral HCV protease inhibitor for hepatitis C

Nov. 12-16, Washington

35th ANNUAL MEETING FOR THE SOCIETY FOR NEUROSCIENCES 2005

Includes presentation from Aeolus Pharmaceuticals Inc. on a lipophilic metalloporphyrin catalytic antioxidant

Nov. 12-17, San Diego

69th ANNUAL SCIENTIFIC MEETING OF THE AMERICAN COLLEGE OF RHEUMATOLOGY

Presentations on latest products and services available to rheumatologists and other physicians and researchers

Nov. 13-16, Dallas

AMERICAN HEART ASSOCIATION CONFERENCE

Includes presentations on data from preclinical small-animal efficacy study of adipose stem and regenerative cells for the treatment of cardiac injury from Cytori Therapeutics, a discussion of rNAPc2 phase 2a acute coronary syndromes data from Nuvelo Inc., data presentation from CV Therapeutics on the anti-anginal efficacy of renolazine and Nuvelo Inc.'s phase 2a trial results rNAPc2 for acute coronary syndrome

Nov. 14-15, Rockville, Md.

CLINICAL PHARMACOLOGY SUBCOMMITTEE OF THE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE (FDA)

Includes update on clinical pharmacology subcommittee meeting recommendations, discussions on translation of pharmacogenetic information into label updates for approved products and critical path pilot project

Nov. 14-18, Philadelphia

AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS: DISCOVERY, BIOLOGY AND CLINICAL APPLICATIONS

Includes sessions on cancer drug discovery and development as well as presentation from Sunesis Pharmaceuticals, Inc. on SNS-595 for cancer and kinase inhibitor programs and presentation from NeoPharm, Inc. on preliminary phase I results of NeoLipid formulation

Nov. 15, Gaithersburg, Md.

PEDIATRIC ETHICS SUBCOMMITTEE OF THE PEDIATRIC ADVISORY COMMITTEE (FDA)

Discussion on an Institutional Review Board referral of a proposed clinical investigation involving children as subjects titled "Gonadotropin-releasing Hormone (GnRH) Agonist Test in Disorders of Puberty"

Nov. 16, Rockville, Md.

CARDIOVASCULAR AND RENAL DRUGS ADVISORY COMMITTEE (FDA)

Discussion on new drug application for Novartis Pharmaceuticals Corp.'s Certican for the proposed indication of prophylaxis of rejection in heart transplantation

Nov. 16-17, Gaithersburg, Md.

PEDIATRIC ADVISORY COMMITTEE (FDA)

Discussion on recommendation from Pediatrics Ethics Subcommittee meeting on Institution Review Board referral and clinical trial designs and devices to treat pediatric obesity

Nov. 16-17, Bethesda, Md.

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE (FDA)

Includes presentation on use of Madin-Darby canine kidney cells for manufacture of inactivated influenza vaccines and pneumococcal vaccines

Nov. 17-18

PEPTIDES AND THERAPEUTIC PROTEINS: NEW OPPORTUNITIES FOR MACROMOLECULE DEVELOPMENT, DELIVERY AND COMMERCIALIZATION

Presentations on how proteins and peptides are becoming therapeutically viable as new technologies, delivery systems and R&D advances are converging to commercialize macromolecules

Nov. 18, Rockville, Md.

ADVISORY COMMITTEE ON SPECIAL STUDIES RELATING TO THE POSSIBLE LONG-TERM HEALTH EFFECTS OF PHENOXY HERBICIDES AND CONTAMINANTS FOR RANCH HAND ADVISORY COMMITTEE (FDA)

Discussion on updates and interactions with the Institute of Medicine's Air Force Health Study disposition study committee

Nov. 18, Gaithersburg, Md.

PEDIATRIC ADVISORY COMMITTEE (FDA)

Discussion on report by the agency on adverse event reporting for Agrylin, Paraplatin, Diflucan, camptosar, Tamiflu, Vioxx, Ferrlecit and Imitrex

Dec. 2, Gaithersburg, Md.

PSYCHOPHARMACOLOGIC DRUGS ADVISORY COMMITTEE (FDA)

Discussion on new drug application for Noven Pharmaceuticals' Methypatch for attention deficit hyperactivity disorder

Dec. 3-6

41st ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY

Includes comparison of minority recruitment of cord blood versus bone marrow donors

Dec. 8-11, San Antonio

28th ANNUAL SAN ANTONIO BREAST CANCER SYMPOSIUM

Geared toward academic and private physicians and researchers involved in breast cancer in medical, surgical and radiation oncology as well as other health care professionals

Dec. 16-19, Washington, D.C.

INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Includes lectures from infectious disease experts, presentations on vaccines and antibiotics

Jan. 19-20, West Conshohocken, Pa.

CENTER FOR BUSINESS INTELLIGENCE CONFERENCE ON SCIENTIFIC STRATEGIES FOR INCREASING EFFICACY, SAFETY AND CONVENIENCE FOR THE NEXT GENERATION OF THERAPEUTICS

Focused on protein therapeutics on the market; includes presentation from Aegis Therapeutics on improvement of protein drugs and technology

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.